Keywords: health, care, drives, 3rd, qtr, rhone-poulenc, net

Health Care Drives 3rd Qtr For Rhone-Poulenc

Article | 04 November 1996

Net income for French chemical and pharmaceutical company Rhone-Poulenc, which holds a 68% stake in R-PR, amounted to 756 million French francs ($148.5 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

docetaxel

Taxotere

Enoxaparin Sodium Injection

Lovenox

Go to drug listing